FDA chief steps down

FDA Commissioner, Scott Gottlieb, who was appointed by President Trump in 2017 is stepping down just shy of two years into his tenure. The commissioner was popular for his market-based policies to lower drug costs and work to speed new brands to approval.

During his time, he worked to avoid drug shortages after a hurricane struck Puerto Rico, led a global investigation into drug impurities, advanced reviews of cell and gene therapies, and bolstered approvals of complex generic drugs.

Click here to view the entire article.